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Neuropathology of hyperkinetic movement disorders can be very challenging. This paper
starts with basic functional anatomy of the basal ganglia in order to appreciate that focal
lesions like for instance tumor or infarction can cause hyperkinetic movement disorders
like (hemi)ballism. The neuropathology of different causes of chorea (amongst others
Huntington’s disease, neuroacanthosis, and HLD-2) and dystonia (DYT1, PD, and Dopa-
Responsive Dystonia) are described. Besides the functional anatomy of the basal ganglia
a wider anatomical network view is provided. This forms the basis for the overview of the
neuropathology of different forms of tremor.
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INTRODUCTION
Several clinical conditions are characterized by the presence of
excessive involuntary movements and are grouped as hyperkinetic
movement disorders. To these disorders belong chorea, ballism,
dystonia, tremor, myoclonus, and tics. Many of these disorders
can be explained by disturbances in the basal ganglia, but it is
important to realize that disruptions outside the basal ganglia may
also cause (combinations of) hyperkinetic movement disorders as
well. A network view in which the basal ganglia participate may
be necessary to understand the neurological symptomatology of
a patient (Neychev et al., 2011). However, a basic understanding
of the normal functional anatomy of the basal ganglia themselves
can assist in the neuropathological evaluation of hyperkinesias.
There are many causes for disturbances in the basal ganglia
and therefore only the most occurring will be described in more
detail in this paper. It is important to understand, however, that
some structural changes, due to for instance infarcts, hemorrhages,
and tumors are not restricted to anatomical boundaries and thus
may lead to complex (combinations of) movement disorders.
Clinicopathological correlations can also be challenging with mul-
tiple affected areas lying in close proximity: choreatic or dystonic
Abbreviations: AVED, ataxia with vitamin E deficiency; CBD, cortico-basal degen-
eration; CM/PF, centromedian nucleus; DBS, deep brain stimulation; DRD, dopa-
responsive dystonia; DRPLA, dentato-rubro-pallido-luysian atrophy; ET, essential
tremor; GPi, globus pallidus internal segment; HD, Huntington’s disease; HDL-1,
-2, -3, Huntington’s disease-like-1, -2, -3; MELAS, mitochondrial encephalomy-
opathy, lactic acidosis, and stroke-like episodes; MERFF, myoclonic epilepsy with
ragged red fibers; MS, multiple sclerosis; MSA, multiple system atrophy; MTPT, 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine; nii, neuronal intranuclear inclusion;
PD, Parkinson’s disease; PET, positron emission tomography; PPN, pedunculo-
pontine nucleus; SCA, spino-cerebellar ataxia; SNc, substantia nigra pars compacta;
STN, subthalamic nucleus; TDP43, TarDNA-binding protein 43.
movement disorders may both be the result of damage of the stria-
tum. Furthermore, the same type of movement disorder might be
the result of damage at different anatomical locations. Last but not
least it is important to understand that some movement disorders
cannot be simply explained by changes at macro-anatomical level.
These functional disturbances can for instance be caused by side
effects of medication (Reich, 2010).
Clinicopathological correlation is an established method to link
neurological (dys)function to a specific/responsible brain region.
In that regard the neuropathologist should work together with the
patient’s clinicians. There are, however drawbacks to this method
(Neychev et al., 2011). Routine histology may not show any tis-
sue changes, but application of more sophisticated methods may
be necessary, for instance using specific monoclonal antibodies.
Questions may remain whether a certain type of histopathological
lesion is also responsible for the neurological disorder. Further-
more, as mentioned earlier, evaluating histopathology could be
biased toward structural changes/defects, whereas metabolic or
physiological disturbances may be more relevant.
In the following, first the functional neuroanatomy of the basal
ganglia in health and disease will be described. Thereafter, chorea,
ballism, dystonia, and tremor will be described with their differen-
tial diagnoses and the (specific) neuropathological changes when
present. As we shall see, for some forms of hyperkinetic move-
ment disorders there is surprisingly little neuropathological data
available in the literature.
FUNCTIONAL NEUROANATOMY AND THE RELATION WITH
MOVEMENT DISORDERS
The basal ganglia encompass the striatum (caudate nucleus
and putamen), globus pallidus, subthalamic nucleus (STN),
and substantia nigra. This “extrapyramidal” system constitutes
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a number of interrelated circuits from which output emerges
at different levels. Although the cortical pyramidal and subcor-
tical extrapyramidal systems do not work independently from
one another, the term extrapyramidal motor system is conve-
nient, because its centers are (at least to some extent) implicated
in the pathogenesis of several movement disorders including the
hyperkinesias.
Besides motor control, which is mostly originating from the lat-
eral compartments of the basal ganglia, there also exist “ventral”
and “limbic” compartments, involved in cognitive functions such
as learning and memory. The nucleus accumbens and substantia
innominata are considered the ventral portions of the striatum
and globus pallidus respectively. Also the accumbens receives
dopaminergic input originating from the ventral tegmental area.
I mention this specifically, because basal ganglia pathology may
also lead to non-motor changes/pathology. Lesions of the caudate
nucleus, for instance, may lead to apathy with loss of initiative in
a significant portion of the patients (Bhatia and Marsden, 1994).
INPUT
The striatum is the most important input system of the basal
ganglia receiving glutamatergic fibers from the cerebral cortex, in
particular the motor areas of the frontal lobe (Brodmann areas 4
and 6; Figure 1A). These fibers are topically organized and orig-
inate from projection neurons of the fifth layer (Alexander et al.,
1986). Besides the motor and premotor cortices, further inputs
come from the centromedian nucleus of the thalamus, substantia
nigra, and oral raphe nuclei (Figure 1A).
FIGURE 1 | Macroscopic pictures of human brain sections with
superimposed schematic drawings showing striatal input (A), striatal
output (B), the direct (C), and indirect (D) pathways. Striatal input comes
from 1: motor cortex, 2: thalamus, 3: oral raphe nuclei, and 4: substantia
nigra. Striatal output is via 1: extern pallidum, 2: intern pallidum, and 3:
substantia nigra. The blue arrows in (C) and (D) indicate
stimulatory/glutamatergic neurotransmission and the red arrows
inhibitory/GABAergic neurotransmission.
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The striatum consists of two compartments: the patch and
the extrastriosomal matrix. These receive different inputs and
have different targets. Imbalanced activity between these com-
partments likely underlies the occurrence of stereotypies (Saka
et al., 2004). Specific degeneration of the striatum occurs in Hunt-
ington’s disease (HD), a well known cause for chorea. Also in
other forms of neurodegenerative diseases, the striatum may be
affected, for instance in Multiple System Atrophy (MSA) and
Cortico-Basal Degeneration (CBD). Damage to the striatum may
also be the result from toxicity, for instance in Wilson’s disease.
It is, however, important to realize that these diseases might also
affect other brain areas, thus resulting in a more complex clinical
picture.
Besides the neocortex, glutamatergic innervation of the stria-
tum also comes from the thalamus; especially the caudal intralam-
inar nuclei. Deep Brain Stimulation (DBS) of these nuclei can alle-
viate some of the symptoms seen in Parkinson’s disease (PD) and
Tourette’s syndrome. Interestingly, thalamic inputs generate more
profuse fields of axon terminals than do cortical axons. Further-
more, thalamic fibers may innervate some striatal interneurons,
but not other populations of striatal neurons. The variegated glu-
tamatergic innervations by neocortex and thalamus gives rise to
a complex picture of striatal stimulation and damage to either
of these input systems could cause a neurochemical disbalance
in the striatum. For instance, post-mortem studies in PSP, HD,
or PD patients showed up to 50% neuronal loss in the centrome-
dian thalamic complex, thereby contributing to the clinical picture
(Henderson et al., 2000).
Apart from glutamatergic innervation, the striatum receives
input from dopaminergic midbrain neurons, especially from the
ventral part of the Substantia Nigra pars compacta (SNc), which
is the most sensitive region in PD (Kish et al., 1998). The loss
of dopaminergic mediated regulation of striatal transmission is
typical in PD. Furthermore, in PD massive loss of spines in the
striatum likely contributes to imbalances in processing extrinsic
inputs to the striatum. On the contrary, heightened dopamin-
ergic activity may induce chorea, as can be seen in levodopa
treated PD patients or in patients who develop dopamine super-
sensitivity from chronic neuroleptic therapy (tardive dyskinesia;
Shoulson, 1986). Also in a rat HD model a hyperdopaminergic sta-
tus was found that was not necessarily related to striatal shrinkage
(Jahanshahi et al., 2010).
Additionally, the striatum receives serotonergic input from the
oral raphe nuclei and noradrenergic innervations from the locus
coeruleus. Both of these nuclei show degenerative changes in a
variety of neurodegenerative diseases (amongst others PD) and
contribute to the clinical picture (Braak et al., 2003; Alafuzoff et al.,
2009).
OUTPUT
The output of the striatum is organized via the external and inter-
nal segments of the Globus Pallidus (GPe/GPi), thus giving rise to
the indirect and direct pathways respectively (Figures 1B–D). The
concept of direct and indirect pathways in the basal ganglia can
help to explain some of the movement disorders described in this
article (see also Figure 2). Furthermore this concept lead to the
FIGURE 2 | Schematic representations of the combined direct and
indirect pathways in health (A) and disease.The colors of the
anatomical structures and the arrows correspond with Figure 1. As
Parkinson’s disease is the second most occurring form of
neurodegenerative disease, it is mentioned here in (B). Due to
degeneration of the substantia nigra (SN), the subthalamic nucleus (STN)
becomes hyperactive. STN deep brain stimulation (C) restores this
disbalance again. Degeneration of the striatum in for instance Huntington’s
disease (D), the STN in for instance infarcts (E), or the pallidum (F) will
lead to different forms of hyperkinesia.
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development of surgical approaches aimed at for instance the GPi
(Obeso et al., 2008).
The Subthalamic Nucleus is a small nucleus in the indirect path-
way and considered the pacemaker of the basal ganglia (Smith,
2012). The STN is the primary surgical target in PD disease (see
Figure 2C). Specific degeneration of the STN is considered the
cause of ballism (see Figure 2E). However, defective disinhibition
of the thalamus by the STN may also produce chorea (John-
son and Fahn, 1977). Often the onset is sudden and caused by
a small infarction or hemorrhage. It is however important to real-
ize that also the STN is more or less affected in various forms of
neurodegenerative diseases.
This global overview of the functional anatomy of the basal
ganglia may help in the neuropathological evaluation (for instance
in the search of focal lesions) and correlation with the clinical
picture. The following part of this article will describe the dif-
ferential diagnosis of the different hyperkinesias and the typical
neuropathological pictures of the more occurring diseases.
NEUROPATHOLOGY OF CHOREA
There are many causes of chorea, which may be hereditary,
secondary (infections, immunologic, drug-induced, metabolic,
endocrine, or vascular), or of unknown etiology (Shoulson, 1986;
Mark, 2012). Especially some of the most occurring hereditary
neurodegenerative diseases with rather specific histopathological
reaction patterns will be described here.
Huntington’s disease usually appears in adult life and is caused
by a mutation in the huntingtin (htt) gene. This progressive
neurodegenerative disease is characterized by a movement dis-
order, dementia, and personality changes. Typically the striatum
shows various degrees of degeneration/neuronal loss (Vonsattel
et al., 1985) and gliosis (Figure 3). Widespread cortical atrophy
may also be present. Less well known, is probably the degeneration
of the premotor oculomotor brainstem system and the cerebellum
(Rub et al., 2009, 2012).
In the mutated htt-gene an elongated CAG-repeat is present,
giving rise to an elongated polyglutamine (polyQ) stretch, which
accumulates during breakdown, in turn giving rise to proteina-
ceous inclusions. Using htt-specific antibodies, or more general
polyQ-antibodies like the 1C2-clone, various forms of protein
aggregations can be observed (Figure 3). Besides the hallmark
lesion, e.g., the neuronal intranuclear inclusion (NII), diffuse
nuclear staining, granular cytoplasmic staining, and neuritic stain-
ing may be observed (Figure 3). Other polyQ-diseases [like sev-
eral of the spino-cerebellar ataxias (SCA), dentato-rubro-pallido-
luysian atrophy (DRPLA), or HD-Like 2 (HDL2)] show similar
staining patterns (Seidel et al., 2010, 2011). They can be dif-
ferentiated however, based upon the variegated neuroanatomi-
cal degeneration throughout the nervous system and the den-
sity/neuroanatomical distribution of the different inclusion pat-
terns (Seidel et al., 2012).
Other conditions in which chorea is a major manifestation
can often be excluded on clinical grounds. The most common
other form of hereditary adult-onset chorea is neuroacanthosis,
presenting with mild chorea, tics, feeding dystonia, and red cell
acanthocytes. Interestingly as with HD, a young age at onset is
FIGURE 3 | Micrographs of the striatum in Huntington’s disease.
(A) Shows a normal age matched control (H&E staining). In (B) the number of
neurons is lower and astrogliosis is already apparent. (C) Shows a GFAP
immunohistochemical staining highlighting the astrogliosis. In (D) the
hallmark lesion: neuronal intranuclear inclusion can be observed. (E,F) Show
1c2 immunohistochemistry. In neuron in (E) also shows diffuse nuclear
staining as well as granular cytoplasmic staining. (F) Shows aggregated polyQ
protein in a neurite.
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FIGURE 4 | Micrographs of the mesencephalon in Parkinson’s
disease (A–C), mutiple system atrophy (D) and progressive
supranuclear palsy (E–G). (A) Shows an H&E staining of the substantia
nigra with neuronal degeneration and phagocytosis of neuromelanin
(arrows). (B) Shows a neuron with two classical Lewy bodies. (C) Shows
alfa-synuclein staining with positive staining of a Lewy body (long arrow)
and Lewy neuritis (short arrows). MSA is also an alfa-synucleinopathy (D)
with both neuronal (long arrow) and oligodendroglial (short arrows)
inclusions. (E) Shows a neuron in PSP with a filamentous basophilic
inclusion (H&E staining). (F,G) Show immunohistochemical stainings for
hyperphosphorylated tau-protein (AT8 clone) with inclusions in a neuron
and “tufted” astrocyte respectively.
more likely to produce parkinsonism and dystonia rather than
chorea. Neuropathology is similar to HD with regard to the striatal
neurodegeneration and gliosis. PolyQ-inclusion bodies, however,
are absent.
Dentato-Rubro-Pallido-Luysian Atrophy is another autoso-
mal disorder, mainly described in Japanese and the result of an
expanded CAG-repeat (Seidel et al., 2012). DRPLA clinically over-
laps with HD and shows combinations of chorea, myoclonus,
seizures, ataxia, and dementia. Neurodegeneration is centered in
the cerebello and pallidofugal systems, but degenerative changes
as well as polyQ inclusions can be found in many nuclei.
Other PolyQ-disorders that can present with chorea are SCA17
and HDL2. Whereas the types of protein inclusions may be the
same as in HD,the density and distribution patterns differ amongst
the various diseases.
HDL1 is caused by an octapeptide repeat in the prion protein
and HLD3 is a misnomer as it appears to be an autosomal-recessive
neurodegenerative disorder beginning in early childhood and
besides chorea and dystonia characterized by spasticity, seizures,
mutism, intellectual impairment, and neuropathologically with
frontal and striatal degeneration.
Senile chorea is a late-onset generalized chorea with no fam-
ily history or dementia and should be considered a diagnose
per exclusionem. Slow progression of the intensity and extent
of the involuntary movements occurs. With DNA testing, up to
50% of these patients do show a CAG-expansion in the htt-gene.
This could be due to (1) a de novo-mutation or (2) the fact
that the patient is ignorant of the family history or (3) may
deny that history. Neuropathological evaluation of the striatum
therefore should include anti-PolyQ immunohistochemistry or
more general inclusion markers like ubiquitin and/or p62 (Seidel
et al., 2009). When positive a more extensive range of anatomical
structures should be evaluated with the same antibodies.
Still other patients with late-onset generalized choreatic move-
ment disorders can be diagnosed with for instance Fahr’s disease,
or antiphospholipid antibody syndrome. Despite extensive clini-
copathological evaluation a patient can remain undiagnosed and
go under the term senile chorea. Degenerative and gliotic changes
are found in the caudate nucleus and putamen, but not to the
extent as seen in HD.
Unilateral and mostly more violent choreatic movements may
develop in middle-aged or elderly patients. The sudden onset sug-
gests a (strategic) vascular basis, which can both be hemorrhagic
or ischemic. Much less common are tumors or plaques in Mul-
tiple Sclerosis. Obviously the neuropathological reaction patterns
in these diseases are not specific for the basal ganglia.
NEUROPATHOLOGY OF DYSTONIA
The term dystonia was coined by Oppenheim in 1911 and is
nowadays defined as a syndrome of sustained muscle contraction,
frequently causing twisting and repetitive movements or abnormal
postures (Fahn, 1984). Dystonia can be classified by age of onset, by
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FIGURE 5 | Scheme showing a more extensive neuroanatomical view
to understand some forms of dystonia and tremor.
distribution (focal, segmental, generalized, or hemidystonia) or by
etiology (primary/idiopathic, secondary, or heredodegenerative).
Gross and light microscopical examination does not reveal con-
sistent histomorphological changes. In fact there is surprisingly
little data on the histopathological features of dystonia (Standaert,
2011). Striatal and dopaminergic dysfunction is suspected to play
a role, which is based upon: (1) imaging or pathology of focal
(unilateral) lesions in the putamen, leading to (hemi)dystonia,
(2) pathology that can be seen in non-primary dystonias, such
as infarction of the lentiform nucleus, Wilson disease, glutaric
aciduria, or neurodegeneration with brain iron accumulation,
(3) combinations with other movement disorders with known
involvement of the basal ganglia such as PD (Figure 4) or HD, (4)
neurosurgical interventions in the basal ganglia that can alleviate
dystonia, (5) sophisticated imaging methods showing abnormal-
ities in the activity of the basal ganglia, and (6) animal studies
(Neychev et al., 2011). It is, however, important to mention that
there is accumulating evidence that abnormalities outside the basal
ganglia (cerebral cortex, cerebellum, brainstem nuclei) can also
cause dystonia (Argyelan et al., 2009).
The number of autopsy reports on primary dystonia is very
limited and the first gene (DYT1) was not identified until 1997.
Reports before this date thus lack the appropriate genetic back-
ground. The articles before 1997 describe various results: some
patients showed neurodegeneration in the SNc, Locus Coeruleus,
raphe nuclei, Pedunculo-Pontine Nucleus (PPN), and dentate ncl,
while some patients did not show any histopathological changes
at all (Kulisevsky et al., 1988; Zweig et al., 1988; Mark et al., 1994).
Furthermore, in some patients with neurodegenerative changes
neurofibrillary tangles (Zweig et al., 1988) or Lewy body pathol-
ogy (Kulisevsky et al., 1988; Mark et al., 1994) could be found and it
is therefore questionable whether some of these cases were indeed
primary (pure) forms of dystonia and not forms of CBD/PSP
(Figure 4) or Diffuse Lewy Body Disease.
Also from genetically confirmed cases of dystonia little neu-
ropathological data is available. In four papers a total of 10 DYT1-
autopsies were described, which showed no signs of neuronal
loss, inflammation, or lack of dopamine content (Furukawa et al.,
2000; Augood et al., 2002; Walker et al., 2002). McNaught et al.
(2004) described four additional DYT1 cases and found ubiqui-
tin and torsinA-positive (Rostasy et al., 2003) neuronal inclusions
in several brainstem nuclei. Although these observations have not
been replicated by others, similar inclusions have been found in
DYT1 mouse models (Granata et al., 2009). No pathology has been
described so far for DYT6 and DYT11.
Dopa-responsive dystonia (DRD) is, as the name implies, a
group of disorders that show clinical improvement with dopamin-
ergic therapies. DYT5 (also called Segawa disease) is the best
described form. DYT14 is related to DYT5 and autopsy studies
in these patients show marked depigmentation of neurons in de
SN. In one case Lewy bodies were described in the SN, but in other
cases no neurodegeneration or inclusions were observed.
Dystonia is a feature that can occur in a wide range of
destructive or neurodegenerative diseases. Perhaps the most com-
mon degenerative cause of dystonia is PD! Other degenera-
tive diseases that might cause dystonia-plus syndromes are PSP,
CBD, and MSA (Figure 4). Hereditary forms may be autosomal
dominant (for instance HD, SCA3, Fahr disease, DRPLA, etc),
autosomal-recessive [for instance Gangliosidosis, Ataxia Telang-
iectasia, Ataxia with Vitamin E Deficiency (AVED)], X-linked
(for instance Lubag/DYT3), or mitochondrial (for instance Leigh,
MERFF/MELAS; Fahn et al., 1998).
Apart from basal ganglia pathology, also changes in the brain-
stem and cerebellum may induce dystonic symptoms (Argyelan
et al., 2009). Interestingly, cervical dystonia has been described to
be triggered by posterior fossa tumors. Furthermore, also in famil-
ial forms of ataxia, dystonic features have been described. As we
shall see in the next part of this article other forms of hyperkinetic
movement disorders like tremors may also occur due to lesions
outside the basal ganglia circuitry.
NEUROPATHOLOGY OF TREMOR
Many forms of tremor exist and distinctions can be made based
upon clinical grounds and electrophysiological recordings. Besides
which body parts shows tremor, a distinction can be made whether
the tremor occurs in rest, during movement or intentional. Before
discussing the more common forms of tremor and the rather
limited (specific) neuropathology, it is necessary to broaden our
view of the functional neuroanatomy. Based upon focal lesions
as well as advanced imaging it has become clear that the cere-
bellar cortex, some deep cerebellar nuclei (dentate, globose, and
emboliform), red nucleus, inferior olive, spinal cord (tracts), and
peripheral nerves have to be added to the circuitry described ear-
lier (Figure 5). PET studies have shown increases in blood flow
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FIGURE 6 | Micrographs showing a normal cerebellar cortex (A) and
(B) as well as cerebellar cortical degeneration (C–F). In (A) (H&E
staining) and (B) (GFAP staining) the molecular layer (ml), Purkinje cell
layer (pc), granular layer (gl), and cerebellar white matter (wm) can be
readily distinguished. (C–F) Show respectively Purkinje cell and granular
cell loss with formation of axonal torpedoes [short arrow in (D)], empty
baskets [arrows in (E)], and Bergmann astrogliosis where the Purkinje
cells have disappeared.
in the cerebellar cortex in many forms of tremor, such as tremor
in PD and Essential tremor (ET; Boecker and Brooks, 1998). The
cerebellum receives input from many sources and projects to the
thalamus, red nucleus and inferior olive. Whether the cerebellar
hyperactivity is cause or a non-specific consequence of the tremor
is matter of debate. The same can be said from the nucleus ven-
tralis intermedius of the thalamus, even though it is the preferred
location for DBS in virtually every form of tremor (Schuurman
et al., 2000; Krauss et al., 2001). It could well be that the Vim and
its connections facilitate the development of the tremor, but that
the source can originate from virtually any location in the motor
system shown in Figure 5 (Elble, 2012).
Essential tremor is the most occurring form of tremor and can
occur at any age, although the prevalence increases with age. The
hallmark of this progressive disease is a kinetic tremor of the arms
although other types of tremors and other motor (ataxia) and
non-motor (dementia) symptoms may occur (Benito-León,2008).
Although many patients have a positive family history, genetic
linkage studies have not found a gene yet. In the relatively scarce
post-mortem examinations of ET brains degenerative changes
have been seen in the cerebellar cortex with loss of Purkinje cells
(PC) and the formation of PC axonal torpedoes (Figure 6). In a
smaller number of brains also Lewy bodies have been found in
the brain stem with relatively normal cerebella (Louis et al., 2007;
Louis, 2010). Furthermore, one other case of ET had ubiquitin
and p62 positive PC intranuclear inclusions. In this case no patho-
logical tau-protein, TDP43 or alfa-synuclein was found. Genetic
analysis excluded SCA1, SCA2, SCA3, SCA6, SCA7, and Fragile X
Tremor Ataxia Syndrome (Louis et al., 2012).
In PD a rest tremor is mostly observed, but action tremors also
frequently occur. In animal studies destruction of the SNc with
MTPT lead to both forms of tremors (Bergman et al., 1998). The
hallmark of PD is neuronal loss of the SNc. Many parts of the
motor system seem to be involved in the production of the rest
tremor as DBS of STN, pallidum, and ventrolateral thalamus can
all suppress the tremor.
The cerebellar intention tremor is often irregular and affects
the proximal limb muscles more than the distal ones. Typically
patients present with lesions in the cerebellum (Figure 6) or
the fiber tracts from the deep cerebellar nuclei (dentate, globose,
emboliform) to the contralateral ventrolateral thalamus. Small
lesions in the vicinity of the ventrolateral thalamus may cause
an intention tremor, but without ataxia (Qureshi et al., 1996).
Holmes tremor shows a combination of resting, postural and
kinetic tremor. Lesions in the vicinity of the ventrolateral thal-
amus and/or the red nucleus as well as surrounding fiber tracts
may explain this combination of tremors. Holmes tremor typically
begins weeks to months after a thalamic or midbrain stroke. There-
fore, secondary or compensatory mechanisms in the motor system,
rather than the damaged compartments themselves may cause
this tremor. Post-stroke tremor without lesions in the midbrain,
superior cerebellar peduncle, or the cerebellum is very rare.
Palatal tremor (also called palatal myoclonus) occurs in two
forms: symptomatic and essential. In the former (which often
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Chorea HD Degeneration in striatum, frontal cortex, brain stem,
cerebellum+gliosis+protein inclusions
1C2+/huntingtin+
Neuroacanthosis Striatal degeneration+gliosis (no protein inclusions) 1C2−
DRPLA Degeneration in pallidum, STN, dentate, and red nucleus+protein
inclusions
1C2+/atrophin-1
SCA17 Degeneration in striatum, ventral thalamus, SN, inferior olive,
cerebellum+protein inclusions
1C2+/TBP
HDL2 Degeneration and protein inclusions largely comparable to HD 1C2+
HDL1 ?? Neuropathology?
HDL3 ?? Neuropathology?
Dystonia DYT1 Degeneration of SNc, LC, raphe nuclei, PPN, and dentate Ub+, TorsinA+ Concomitant
tangles/Lewy bodies?
DYT6 and DYT11 ?? Neuropathology?
DYT5/DYT14 SN neurodegeneration; 1 case with Lewy bodies Concomitant Lewy
bodies?
LUBAG/DYT3 Mosaic neuronal loss in caudate and lateral putamen+gliosis
PD Diffuse degeneration throughout the CNS (six stages) with Lewy
bodies, pale bodies, and Lewy neurites
Alfa-synuclein
PSP Degeneration of SN, locus coeruleus, pons, midbrain,
pallidum+neuronal and glial protein inclusions
tau
CBD Degeneration in SN, pallidum, striatum, STN, thalamus, and red
nucleus+neuronal and glial protein inclusions
tau
MSA Variable degeneration of olivo-ponto-cerebellar system and basal
ganglia+neuronal+glial protein inclusions
Alfa-synuclein
Tremor ET Cerebellar cortical degeneration LB in brainstem
concomitant?
Ub+/p62+ nii specific?
PD See above Alfa-synuclein
Cerebellar tremor Lesions in cerebellum or fiber tracts from deep cerebellar nuclei
Holmes tremor Lesions in ventrolateral thalamus/red nucleus or surrounding fiber
tracts
Palatal tremor Degeneration of dentate-olivary pathway+ secondary hypertrophy
of inferior olive
Li induced tremor Neuronal loss+gliosis in cerebellar cortex and dentate nucleus
shows other brainstem and cerebellar signs) neuropathology has
found secondary hypertrophy of the inferior olive as a consequence
of damage to the dentate-olivary pathway. In the latter an annoy-
ing ear clicking is present without other neurological symptoms
and the pathology is not clear.
It is important to realize that many other tremors exist, such
as orthostatic tremor, tremor due to peripheral nerve pathology,
drug-induced tremor, and psychogenic tremor. For neuropathol-
ogy it is interesting to mention persistent lithium-induced tremor
accompanied by ataxia, as patients may show neuronal loss and
gliosis of the cerebellar cortex (Figure 6) and dentate nuclei
(Schneider and Mirra, 1994).
CONCLUDING REMARKS
For neuropathological diagnostics of hyperkinetic movement dis-
orders it is not only necessary to have a good understanding
of the functional anatomy of the basal ganglia, but also of a
wider network view that includes other structures (amongst oth-
ers the cerebellum). Besides focal lesions, samples should also
be taken from normal appearing brain areas in the above men-
tioned structures in order to look for specific reaction pat-
terns/neurodegeneration. A series of additional stains to evaluate
these patterns more clearly will be necessary as well as ubiquitin
or p62 stainings to evaluate the general presence of proteina-
ceous aggregated material. Depending on the type and distribution
of the aggregates more specific immunohistochemical stains can
be added (see also Table 1). Contact with the referring clin-
ician is warranted in order to correlate the neuropathological
findings with the clinical picture. The neuropathologist should
keep in mind that direct clinicopathological correlations are not
always present and that functional disturbances could also cause
hyperkinesias.
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